These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: a meta-analysis. Zhao Z; Liao G; Li Y; Zhou S; Zou H Sci Rep; 2015 Feb; 5():8219. PubMed ID: 25645999 [TBL] [Abstract][Full Text] [Related]
8. Rituximab in steroid-dependent nephrotic syndrome. El Koumi M Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100 [TBL] [Abstract][Full Text] [Related]
9. Rituximab in patients with the steroid-resistant nephrotic syndrome. Bagga A; Sinha A; Moudgil A N Engl J Med; 2007 Jun; 356(26):2751-2. PubMed ID: 17596616 [No Abstract] [Full Text] [Related]
10. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab. Kamei K; Ishikura K; Sako M; Aya K; Tanaka R; Nozu K; Kaito H; Nakanishi K; Ohtomo Y; Miura K; Takahashi S; Morimoto T; Kubota W; Ito S; Nakamura H; Iijima K; Pediatr Nephrol; 2017 Nov; 32(11):2071-2078. PubMed ID: 28664242 [TBL] [Abstract][Full Text] [Related]
11. Rituximab efficiency in children with steroid-dependent nephrotic syndrome. Sellier-Leclerc AL; Macher MA; Loirat C; Guérin V; Watier H; Peuchmaur M; Baudouin V; Deschênes G Pediatr Nephrol; 2010 Jun; 25(6):1109-15. PubMed ID: 20238230 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome. Hoseini R; Sabzian K; Otukesh H; Zafaranloo N; Panahi P; Rahimzadeh N; Nakhaie S; Akhavan Sepehi M Iran J Kidney Dis; 2018 Jan; 12(1):27-32. PubMed ID: 29421774 [TBL] [Abstract][Full Text] [Related]
14. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome. Miyabe Y; Takei T; Iwabuchi Y; Moriyama T; Nitta K Clin Exp Nephrol; 2016 Feb; 20(1):103-10. PubMed ID: 26138356 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab. Kamei K; Ogura M; Sato M; Sako M; Iijima K; Ito S Pediatr Nephrol; 2016 Jan; 31(1):89-95. PubMed ID: 26341251 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome. Sinha A; Bhatia D; Gulati A; Rawat M; Dinda AK; Hari P; Bagga A Nephrol Dial Transplant; 2015 Jan; 30(1):96-106. PubMed ID: 25121488 [TBL] [Abstract][Full Text] [Related]
17. A mild form of rituximab-associated lung injury in two adolescents treated for nephrotic syndrome. Spatafora M; Bellini T; Giordano C; Ghiggeri GM BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26661285 [TBL] [Abstract][Full Text] [Related]
18. B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome. Colucci M; Carsetti R; Cascioli S; Casiraghi F; Perna A; Ravà L; Ruggiero B; Emma F; Vivarelli M J Am Soc Nephrol; 2016 Jun; 27(6):1811-22. PubMed ID: 26567244 [TBL] [Abstract][Full Text] [Related]